$0.620100
-0.07-10.69%
Pre-Market: Nov 18, 6:53 PM EDT
Comments
Loading...
Hepion Pharmaceuticals (HEPA) Forecast
NewsEarningsHepion Pharmaceuticals (HEPA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestHepion Pharmaceuticals (NASDAQ:HEPA) Stock Quotes, Forecast and News Summary
Hepion Pharmaceuticals Stock (NASDAQ: HEPA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Hepion Pharmaceuticals (HEPA) stock?
You can purchase shares of Hepion Pharmaceuticals (NASDAQ:HEPA) through any online brokerage.
Who are Hepion Pharmaceuticals (HEPA) competitors?
Other companies in Hepion Pharmaceuticals’s space includes: 60 Degrees (NASDAQ:SXTP), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN) and Jaguar Health (NASDAQ:JAGX).
What is the forecast, or price target, for Hepion Pharmaceuticals (HEPA) stock?
Hepion Pharmaceuticals has a consensus price target of $3.50.
What is the current price for Hepion Pharmaceuticals (HEPA)?
The stock price for Hepion Pharmaceuticals (NASDAQ: HEPA) is $0.6201 last updated November 18, 2024 at 6:53 PM EST.
Does Hepion Pharmaceuticals (HEPA) pay a dividend?
There are no upcoming dividends for Hepion Pharmaceuticals.
When is Hepion Pharmaceuticals (NASDAQ:HEPA) reporting earnings?
Hepion Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Hepion Pharmaceuticals (HEPA) going to split?
There is no upcoming split for Hepion Pharmaceuticals.
What sector and industry does Hepion Pharmaceuticals (HEPA) operate in?
Hepion Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.